UH Mānoa researchers published the first live, in‑situ footage of goblin sharks, documenting Central Pacific sightings that extend the species’ depth and range.

Pitt researchers turned a harmless eye bacterium into a prototype "living eye drop" that secretes anti-inflammatory IL-10 and sped cornea healing in mice. The proof-of-concept could reduce repeated dosing, but human trials are still distant.

Ángel Cabrera will step down as Georgia Tech president this November to lead the Aspen Institute; he will remain through the holidays to oversee the transition.

Nvidia plans to sell at least $20 billion of bonds in a seven‑part offering to refinance debt and fund AI investments.

UCSF researchers describe an implanted adaptive DBS system that times stimulation to walking and reduced falls in a small Parkinson's feasibility trial.

UC San Diego and Stanford researchers found brief electrical pulses rejuvenated sea squirts and raised questions about stem‑cell aging in people.

UT Austin and MD Anderson launched a cross‑campus accelerator funding five projects to speed protein therapies, AI and surgical robotics into patient care.

Phoenix is expanding apprenticeships into biomanufacturing to train residents for GLP‑1 drug production, turning regional biotech demand into local job pathways.

Nano Dimension signed a non‑binding term sheet to merge with Infinite Epigenetics in a proposed $890M stock deal that would pivot the Waltham company into AI‑powered health diagnostics. The combined firm would seek the Nasdaq ticker IEAI and access to more than $400M in cash at closing.

Salesforce agreed to buy Fin for about $3.6 billion to fold a leading AI customer agent into its Agentforce platform. The deal sharpens San Francisco’s role in enterprise AI consolidation.

UNT Health Fort Worth is the first Texas site in a national study probing why most adults with Down syndrome develop Alzheimer’s. The study will offer free imaging and testing to eligible participants.

Anthropic is committing up to $15 million in Claude credits to help state and local governments scan for and fix software vulnerabilities, with California and Texas among early participants.

A New York‑led coalition of state attorneys general served OpenAI with a sweeping subpoena seeking memos on advertising, retention, data and child and senior safety as the company confirms a confidential IPO filing.